Index by author

September 01, 2002; Volume 29,Issue 9

  1. Adachi, Nobuo

    1. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects.
      Nobuo Adachi, Kenji Sato, Arvydas Usas, Freddie H Fu, Mitsuo Ochi, Chang-Whan Han, Christopher Niyibizi and Johnny Huard
      The Journal of Rheumatology September 1 2002, 29 (9) 1920-1930;

  2. Adams, Brian D

    1. Androgen receptors in human synoviocytes and androgen regulation of interleukin 1beta (IL-1beta) induced IL-6 production: a link between hypoandrogenicity and rheumatoid arthritis?
      Zhila Khalkhali-Ellis, Robert J Handa, Richard H Price Jr, Brian D Adams, John J Callaghan and Mary J C Hendrix
      The Journal of Rheumatology September 1 2002, 29 (9) 1843-1846;

  3. Alegre, Maria-Luisa

    1. Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
      Tammy O Utset, Julie A Auger, Donna Peace, Robert A Zivin, Danlin Xu, Linda Jolliffe, Maria-Luisa Alegre, Jeffrey A Bluestone and Marcus R Clark
      The Journal of Rheumatology September 1 2002, 29 (9) 1907-1913;

  4. Anaya, Juan-Manuel

    1. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism.
      Juan-Manuel Anaya, Paula A Correa, Mónica Herrera, Joyce Eskdale and Grant Gallagher
      The Journal of Rheumatology September 1 2002, 29 (9) 1874-1876;

  5. Andrade, Susan E

    1. Challenges of estimating health service utilization for osteoarthritis patients on a population level.
      Leslie R Harrold, Robert A Yood, Walter Straus, Susan E Andrade, John I Reed, Jackie Cernieux, Barbara Edelman Lewis and Jerry H Gurwitz
      The Journal of Rheumatology September 1 2002, 29 (9) 1931-1936;

  6. Appel, Heiner

    1. Massive splenomegaly and hypersplenism in a young woman with primary Sjögren's syndrome.
      Heiner Appel, Christoph Loddenkemper, Janine Rohweder, Martin Rudwaleit, Martin Zeitz and Joachim Sieper
      The Journal of Rheumatology September 1 2002, 29 (9) 2012-2013;

  7. Asherson, Ronald

    1. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator.
      Arsinur Burcoglu-O'Ral, Doruk Erkan and Ronald Asherson
      The Journal of Rheumatology September 1 2002, 29 (9) 2006-2011;

  8. Assaloni, Roberta

    1. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
      Martina Fabris, Barbara Tolusso, Emma Di Poi, Roberta Assaloni, Luigi Sinigaglia and Gianfranco Ferraccioli
      The Journal of Rheumatology September 1 2002, 29 (9) 1847-1850;

  9. Auberton, Eric

    1. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.
      Elisabeth Dion, Patrick Cherin, Christine Payan, Jean-Charles Fournet, Thomas Papo, Thierry Maisonobe, Eric Auberton, Olivier Chosidow, Pierre Godeau, Jean-Charles Piette, Serge Herson and Philippe Grenier
      The Journal of Rheumatology September 1 2002, 29 (9) 1897-1906;

  10. Auger, Julie A

    1. Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
      Tammy O Utset, Julie A Auger, Donna Peace, Robert A Zivin, Danlin Xu, Linda Jolliffe, Maria-Luisa Alegre, Jeffrey A Bluestone and Marcus R Clark
      The Journal of Rheumatology September 1 2002, 29 (9) 1907-1913;
« Previous (Pages : 1 2 3 4 5 6 ... 21) Next »
Back to top

In this issue